Vascular dementia (VaD) is the second leading form of dementia after Alzheimer's disease
(AD) plaguing the elderly population. VaD is a progressive disease caused by reduced …

With the emergence of novel technologies and ground breaking concepts in BBB basic
research in the past decades, the researchers' attention on the critical role of blood brain …

Objective To assess feasibility and safety of providing autologous umbilical cord blood
(UCB) cells to neonates with hypoxic-ischemic encephalopathy (HIE). Study design We …

Neonatal hypoxic-ischaemic encephalopathy (HIE) is a serious condition; many survivors
develop neurological impairments, including cerebral palsy and intellectual disability …

Neonatal hypoxic-ischemic encephalopathy (HIE) is an important cause of mortality and
morbidity in the perinatal period. This condition results from a period of ischemia and …

In term and near-term neonates with neonatal encephalopathy, therapeutic hypothermia
protocols are well established. The current focus is on how to improve outcomes further and …

In the research, clinical, and wider community there is great interest in the use of stem cells
to reduce the progression, or indeed repair brain injury. Perinatal brain injury may result …

Neurological injuries can have numerous debilitating effects on functional status including
sensorimotor deficits, cognitive impairment, and behavioral symptoms. Despite the disease …

Neonatal hypoxic ischemic encephalopathy (HIE) is an important cause of neonatal death
and disability. At present, there is no unified standard and specialized treatment method for …

Neonatal brain injury induced by stroke causes significant disability, including cerebral
palsy, and there is no effective therapy for stroke. Recently, mesenchymal stem cells (MSCs) …